Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

21. Developments in PK/PD modelling and approaches: what to do when the standard model does not describe the data

    Elisabet Nielsen, Uppsala, Sweden

    21 September 2016

    Relevance:

     

    65%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

22. Round table: resources for antibiotic drug discovery - MRC

    Jonathan Pearce, London, United Kingdom

    21 September 2016

    Relevance:

     

    64%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

23. Round table: resources for antibiotic drug discovery - BARDA

    Christopher Houchens, Washington, D.C., United States

    21 September 2016

    Relevance:

     

    64%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

24. Round table: resources for antibiotic drug discovery - NIH

    Francois Franceschi, Rockville, MD, United States

    21 September 2016

    Relevance:

     

    64%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

25. Strength and limitations of pre-clinical models for drug development

    Sujata Bhavnani, Latham, NY, United States

    21 September 2016

    Relevance:

     

    61%

     

    No material available

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

26. Utilizing PK/PD to increase the probability of successful drug development

    Paul Ambrose, Latham, NY, United States

    21 September 2016

    Relevance:

     

    58%

     

    No material available

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

27. Relationship Between Gepotidacin (GSK1440944) Pharmacokinetics-Pharmacodynamics and Escherichia coli Resistance Amplification Prevention in a Hollow-Fiber Infection Model (HFIM)

    Brian VanScoy, Latham, United States

    06 September 2017

    Relevance:

     

    56%

     

    

    Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Boston, United States
    Conference lecture

    Bacterial Susceptibility & Resistance

28. Pharmacokinetics/Pharmacodynamics

    Nikolas Onufrak, Chapel Hill, United States

    07 September 2018

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship

29. Advanced observational studies for MDR pathogens: useful or confounding?

    Michal Paul, Haifa, Israel

    07 September 2018

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship

30. How to define wild type distributions of target organisms

    Maiken Arendrup, Copenhagen, Denmark

    07 September 2018

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship